Search the site

The WAACHS regional profiles look at all four volumes of results across the ATSIC regions of Western Australia.

CRE in Aboriginal Health and Wellbeing (CREAHW)

CREAHW is a program of intervention research focused on achieving sustainable change for the Aboriginal community & improving the lives of Aboriginal people.

WAACHS Volume 2

The social and emotional wellbeing of Aboriginal children and young people

The Kids Kimberley

The aim of establishing a local presence is based upon an intention to be by invitation considered as part of the Kimberley group of organisations as well ...

Indigenous Capacity Building Grant (ICBG)

This was a five year grant from the NHMRC to build research capacity in ten Aboriginal researchers

Two decades of increasing incidence of childhood-onset type 2 diabetes in Western Australia (2000–2019)

This retrospective population‐based study aimed to determine the incidence of type 2 diabetes from 2012 to 2019 in Western Australian youth aged under 16 years, and to examine temporal trends between 2000 and 2019, using data from the Western Australian Children’s Diabetes Database (WACDD). The data extracted for eligible patients diagnosed with type 2 diabetes, according to standard criteria, included diagnosis year, age, sex and self‐reported Aboriginal or Torres Strait Islander status.

The impact of racial discrimination on the health of Australian Indigenous children aged 5–10 years: analysis of national longitudinal data

Direct and persistent vicarious racial discrimination are detrimental to the physical and mental health of Indigenous children in Australia

Aboriginal and Torres Strait Islander children and child sexual abuse in institutional settings

The Royal Commission into Institutional Responses to Child Sexual Abuse commissioned The Kids Research Institute Australia to collaborate on a report

Repeat pneumococcal polysaccharide vaccine in Indigenous Australian adults is associated with decreased immune responsiveness

These findings highlight the critical need to evaluate the efficacy of future pneumococcal vaccine programs in the Australian Indigenous populations that recommend repeated doses of 23vPPV.

Strongyloides seroprevalence before and after an ivermectin mass drug administration in a remote Australian Aboriginal community

We report the impact on Strongyloides seroprevalence after two oral ivermectin mass drug administrations (MDAs) delivered 12 months apart in a remote Australian Aboriginal community.